Invitrogen Corporation and Wisconsin Alumni Research Foundation (WARF) Sign License Agreement for Human Embryonic Stem Cells

Published: May 08, 2008

CARLSBAD, Calif. & MADISON, Wis.--(BUSINESS WIRE)--Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, and the Wisconsin Alumni Research Foundation (WARF), the private, non-profit patenting and licensing organization for the University of Wisconsin-Madison, announced today that they have signed a license for human embryonic stem cell (hESC) patents for the development of research tools.

Back to news